Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-Bipolar RCT: Low Dose Aspirin in Bipolar Disorder
NCT05035316Phase 2Completed
- Start
- Jan 2022
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in bipolar disorder (BD). Started Jan 2022; status: completed.
02
Drugs
aspirin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05035316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035316.